Pioglitazone Hydrochloride and Metformin Hydrochloride
These highlights do not include all the information needed to use PIOGLITAZONE AND METFORMIN HYDROCHLORIDE TABLETS safely and effectively. See full prescribing information for PIOGLITAZONE AND METFORMIN HYDROCHLORIDE TABLETS. PIOGLITAZONE and METFORMIN HYDROCHLORIDE tablets, for oral use Initial U.S. Approval: 2005
8d252dab-e868-42d3-95ea-69423d909e84
HUMAN PRESCRIPTION DRUG LABEL
Oct 27, 2022
Rising Health, LLC
DUNS: 080500961
Rising Pharma Holdings, Inc.
DUNS: 116880195
Products 2
Detailed information about drug products covered under this FDA approval, including NDC codes, dosage forms, ingredients, and administration routes.
Pioglitazone Hydrochloride and Metformin Hydrochloride
Product Details
FDA regulatory identification and product classification information
FDA Identifiers
Product Classification
Product Specifications
INGREDIENTS (10)
Pioglitazone Hydrochloride and Metformin Hydrochloride
Product Details
FDA regulatory identification and product classification information